Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Jun;128(6):631-4.
doi: 10.1001/archotol.128.6.631.

Randomized controlled trials for evaluating surgical questions

Affiliations

Randomized controlled trials for evaluating surgical questions

Eric K Fung et al. Arch Otolaryngol Head Neck Surg. 2002 Jun.

Abstract

Objective: To discuss some of the obstacles inherent in the design of the randomized controlled trial (RCT) that the surgeon must confront and options to minimize these obstacles.

Data sources: The literature was searched for articles discussing RCTs using MEDLINE from 1966 to 1998.

Study selection: Studies relevant to the general use of RCTs for evaluating surgical questions were selected.

Synthesis: Several problems inherent in RCTs were noted: (1) ethical considerations, (2) difficulties in patient accrual, (3) patient preferences, and (4) variability in surgical proficiency/technique. Some means of minimizing these problems are (1) the concept of clinical equipoise, (2) multicenter trials, and (3) stratified sampling of patients. Alternatives to the classic RCT are discussed, namely, the randomized consent design and the patient preference design.

Conclusions: The nature of the RCTs is that they are difficult to use to evaluate surgical techniques. Some options are available to minimize these difficulties. Designing and conducting RCTs to evaluate surgical interventions require careful planning and some compromises. Unless the previously mentioned criteria are applied, the validity of the RCT can be considered no greater than that of other trials.

PubMed Disclaimer

MeSH terms